Extreme bipolar androgen therapy with darolutamide and testosterone cypionate in patients with metastatic castration-resistant prostate cancer: ExBAT (LACOG 0620) trial.

被引：0
|
作者：
Velho, Pedro H. Isaacsson
Girardi, Daniel da Motta
Soares, Andrey
Jardim, Denis Leonardo Fontes
Maluf, Fernando Cotait
Morbeck, Igor Alexandre
Dias, Mariane Fontes
Souza, Vinicius Carrera
E Silva, Adriano Goncalves
de Jesus, Rafaela Gomes
Rebelatto, Taiane Francieli
Bastos, Diogo Assed
机构：
[1] Hosp Moinhos De Vento, Porto Alegre, RS, Brazil
[2] Hosp Sirio Libanes, Brasilia, DF, Brazil
[3] Hosp Israelita Albert Einstein, Sao Paulo, SP, Brazil
[4] Grp Oncoclin, Sao Paulo, SP, Brazil
[5] Hosp Sirio Libanes, Sao Paulo, SP, Brazil
[6] Hosp Benefencia Portuguesa, Sao Paulo, SP, Brazil
[7] Grp Oncoclin, Rio De Janeiro, RJ, Brazil
[8] Hosp Alianca, Oncol DOr, Salvador, BA, Brazil
[9] Inst Canc & Transplante Curitiba ICTr, Curitiba, PR, Brazil
[10] Latin Amer Cooperat Oncol Grp LACOG, Porto Alegre, RS, Brazil
[11] Hosp Sirio Libanes, Sao Paulo, SP, Brazil
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS276
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Darolutamide and survival in nonmetastatic, castration-resistant prostate cancer: a patient perspective of the ARAMIS trial
    Fizazi, K.
    Blue, Ian
    Nowak, Joel T.
    FUTURE ONCOLOGY, 2021, 17 (14) : 1 - 9
  • [42] Phase 1 Trial of High-Dose Exogenous Testosterone in Patients with Castration-Resistant Metastatic Prostate Cancer
    Morris, Michael J.
    Huang, Daisy
    Kelly, William K.
    Slovin, Susan F.
    Stephenson, Ryan D.
    Eicher, Caitlin
    Delacruz, Anthony
    Curley, Tracy
    Schwartz, Lawrence H.
    Scher, Howard I.
    EUROPEAN UROLOGY, 2009, 56 (02) : 237 - 244
  • [43] Impact of Darolutamide on Local Symptoms in Patients With Nonmetastatic Castration-Resistant Prostate Cancer
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (11) : 11 - 12
  • [44] Enzalutamide for patients with metastatic castration-resistant prostate cancer
    Ramadan, Wijdan H.
    Kabbara, Wissam K.
    Al Masri, Hiba S. Al Basiouni
    ONCOTARGETS AND THERAPY, 2015, 8 : 871 - 876
  • [45] IMPACT OF DAROLUTAMIDE ON LOCAL SYMPTOMS IN PATIENTS WITH NONMETASTATIC CASTRATION-RESISTANT PROSTATE CANCER
    Shore, Neal
    Stenzl, Arnulf
    Pieczonka, Christopher
    Klaassen, Zachary
    Aronson, William
    Karsh, Lawrence
    Ryan, Charles
    Miskic, Marina
    Srinivasan, Shankar
    Mohamed, Ateesha
    Verholen, Frank
    JOURNAL OF UROLOGY, 2021, 206 : E586 - E587
  • [46] Biomarker Development Trial of Satraplatin in Patients with Metastatic Castration-Resistant Prostate Cancer
    Liaw, Bobby C.
    Tsao, Che-Kai
    Seng, Sonia
    Jun, Tomi
    Gong, Yixuan
    Galsky, Matthew D.
    Oh, William K.
    ONCOLOGIST, 2022, : 366 - 367+e218
  • [47] Trial design for metastatic castration-resistant prostate cancer - Reply
    Scher, Howard I.
    Halabi, Susan
    Tannock, Ian F.
    Morris, Michael
    Sternberg, Cora N.
    Carducci, Michael A.
    Eisenberger, Mario A.
    Higano, Celestia
    Bubley, Glenn J.
    Dreicer, Robert
    Petrylak, Daniel P.
    Kantoff, Philip
    Basch, Ethan
    Kelly, Wm Kevin
    Figg, William D.
    Small, Eric J.
    Beer, Tomasz M.
    Wilding, George
    Martin, Alison
    Hussain, Maha
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (21) : 3648 - 3649
  • [48] Reversing the effects of androgen-deprivation therapy in men with metastatic castration-resistant prostate cancer
    Marshall, Catherine H.
    Tunacao, Jessa
    Danda, Varun
    Tsai, Hua-Ling
    Barber, John
    Gawande, Rakhee
    Weiss, Clifford R.
    Denmeade, Samuel R.
    Joshu, Corinne
    BJU INTERNATIONAL, 2021, 128 (03) : 366 - 373
  • [49] Molecular and clinical characterization of metastatic castration-resistant prostate cancer (mCRPC) patients achieving deep PSA responses to bipolar androgen therapy (BAT).
    Markowski, Mark Christopher
    Kachhap, Sushant
    De Marzo, Angelo M.
    Denmeade, Samuel R.
    Antonarakis, Emmanuel S.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [50] Clinical Efficacy of Bipolar Androgen Therapy in Men with Metastatic Castration-Resistant Prostate Cancer and Combined Tumor-Suppressor Loss
    Markowski, Mark C.
    Wang, Hao
    De Marzo, Angelo M.
    Schweizer, Michael T.
    Antonarakis, Emmanuel S.
    Denmeade, Samuel R.
    EUROPEAN UROLOGY OPEN SCIENCE, 2022, 41 : 112 - 115
12345